Esomeprazole tablet vs omeprazole capsule in treating erosive esophagitis

Table 1 Demographics and baseline characteristics of erosive esophagitis patients treated with esomeprazole or omeprazole (mean±SE).

	Esomeprazole 40 mg n = 25	Omeprazole 20 mg n = 23	P
Age (yr)	49.2±3.7	59.0±3.4	0.0596
Sex (male%)	20 (80)	18 (78.3)	1.0000
Body weight (kg)	68.4±2.4	70.9±2.5	0.4779
Height (cm)	166.7±1.3	169.0±1.4	0.2096
Basal reflux symptoms (VAS)
Heartburn	29.4±5.7	23.6±5.9	0.2683
Nausea	18.7±5.5	13.8±5.8	0.8520
Regurgitation	29.8±6.1	24.5±6.4	0.3365
Vomiting	14.0±4.7	8.8±4.9	0.5702
Belching	47.0±6.0	25.2±6.3	0.0121
Dysphagia	7.5±5.0	14.7±5.2	0.7421
Epigastric pain	15.8±5.5	16.7±5.8	0.9223
LA grade of erosive esophagitis [n (%)]			0.6617
A	15 (60)	11 (47.8)
B	7 (28)	7 (30.4)
C	2 (8)	2 (8.7)
D	1 (4)	3 (13.0)
Hp infection status	10 (40)	11 (47.8)	0.5643

VAS: visual analog scale, scored from 0 (none) to 100 (most severe); Hp: Helicobacter pylori; LA: Los Angeles.